Sort
48,018 grants matching “immunotherapy”
Mucosal Chemokines and CD8+ T Cell Immunity to Genital Herpes
$603,265Lbachir Benmohamed · University Of California-Irvine · R01 · FY2021 · AI
Defining the role of RIG-I in glaucoma pathogenesis and response to viral infection
$603,251Lev Prasov · University Of Michigan At Ann Arbor · R01 · FY2025 · EY
Metabolism of cancer chemotherapeutics by the human gut microbiome
$603,222Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2023 · CA
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer
$603,179Yuanpei Li · University Of California At Davis · R01 · FY2022 · DE
Mechanisms of immune-epithelial crosstalk in tissue repair
$603,073Shruti Naik · New York University School Of Medicine · R01 · FY2023 · AI
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$603,069David G Denardo · Washington University · R01 · FY2023 · CA
Immune cell control of ovarian cancer
$603,049Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Genomics and Functional Characterization of NF1-mutated Lung Cancer
$603,012Eric Collisson · University Of California, San Francisco · R01 · FY2020 · CA
Beta-Amyloid Immunization in a Canine Model of Aging
$602,979Elizabeth Head · University Of Kentucky · R01 · FY2009 · AG
Ovarian Cancer Epigenetics, Immunity and Therapy
$602,952Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Novel immunotherapies using optimized tumor cell-penetrating antibodies
$602,881Jose R Conejo-Garcia · Duke University · R01 · FY2025 · CA
TOX-driven CD8 T cell differentiation and dysfunction in tumors
$602,850Andrea Schietinger · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
TARGETING EXTRACELLULAR NUCLEOSIDE METABOLISM AS A STRATEGY TO POTENTIATE THE EFFECTS OF IMMUNOTHERAPY IN PANCREATIC DUCTAL ADENOCARCINOMA
$602,814Board Of Regents Of The University Of Nebraska · · FY2024 · Defense Health Agency
A novel preclinical model of spontaneous metastasis
$602,786Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus
$602,743John M Dye · Geneva Foundation · R01 · FY2014 · AI
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer
$602,740Yuanpei Li · University Of California At Davis · R01 · FY2023 · DE
Research Training in Academic Medical Oncology
$602,683Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2023 · CA
CRACD-controlled cell plasticity and small cell lung cancer
$602,680Jae-Il Park · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Investigational Cancer Therapeutics Training Program
$602,650Dean F. Bajorin · Sloan-Kettering Inst Can Research · T32 · FY2020 · CA
Predictive Markers in Metastatic Renal Cancer
$602,629Phillip G Febbo · University Of California, San Francisco · R01 · FY2011 · CA
Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer
$602,576Kian H Lim · Washington University · R01 · FY2025 · CA
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
$602,572Gregoire Stephane Lauvau · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Metabolic control of regulatory T cell functional identity
$602,526Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Metabolic control of regulatory T cell functional identity
$602,526Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Metabolic control of regulatory T cell functional identity
$602,526Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI